REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

AMED Co. Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medical Equipment and Supplies Manufacturing
Full name: AMED Co. Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

AMED Co. Ltd. is engaged in wound care, everything from core technology research and development, manufacturing, distribution marketing, to product health education services. The company’s main products include Wound care, Pain management (pain relief injection), medical devices: Polysite, easyendo. The company was established in 200 and is headquartered in New Taipei City, Taiwan.

Headquarters
No.14-1 Wuquan 7Th Rd, Wugu Dist, New Taipei City 24890, Taiwan
New Taipei City; New Taipei City;

Contact Details: Purchase the AMED Co. Ltd. report to view the information.

Website: http://www.amed.com.tw

Basic Information
Total Employees:
Purchase the AMED Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the AMED Co. Ltd. report to view the information.
Financial Auditors:
Purchase the AMED Co. Ltd. report to view the information.
Incorporation Date:
July 15, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
10.3%
Purchase this report to view the information.
3.81%
Purchase this report to view the information.
1.56%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after AMED Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
13.87%▲
Total operating revenue
13.87%▲
Operating profit (EBIT)
20.67%▲
EBITDA
9.28%▲
Net Profit (Loss) for the Period
27.13%▲
Total assets
6.96%▲
Total equity
29.76%▲
Operating Profit Margin (ROS)
0.82%▲
Net Profit Margin
1.06%▲
Return on Equity (ROE)
-0.2%▼
Debt to Equity Ratio
-32.6%▼
Quick Ratio
0.31%▲
Cash Ratio
0.16%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
Pharmally International Holding Co., Ltd
 
Taiwan Biotech Co., Ltd.
Excelsior Biopharma Inc.
 
PharmaEngine, Inc.
GeneFerm Biotechnology Co., Ltd.
 
UBI Pharma Inc.
Winston Medical Supply Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo